Original article
So far, telemedicine plays a subordinate role in practical diabetology in Germany, which, according to the organizers of the third DDG Future Day „Diabetology & Diabetes Technology“ – Prof. Dr. Dirk Müller-Wieland (DDG President) and Prof. Dr. Lutz Heinemann (Chairman of the DDG Working Group Diabetes & Technology – AGDT) – is due on the one hand to the high density of diabetologists in large parts of Germany, but on the other hand also to shortcomings regarding legal regulations and, above all, to what they consider to be inadequate remuneration.
04.04.2019
The advances in HIV therapy are a success story: thanks to modern medical research, an HIV infection that was fatal within a year 40 years ago is now highly treatable. Patients can thus reach a normal lifespan with a good quality of life. Nevertheless, challenges in treatment remain, such as the rapid replication of the virus and the development of resistance to the antiretroviral drugs used. However, there is a wide range of medications with different mechanisms of action and combination therapies available. This article examines the developments that have shaped HIV therapy and which drug options currently dominate the market.
04.04.2019
Andreas Storm is an experienced politician who served in the German Bundestag for 15 years, as Parliamentary State Secretary in the Federal Ministry of Education and Research, as State Secretary in the Federal Ministry of Labor and Social Affairs, as Head of the Saarland State Chancellery, and as Minister of Health in Saarland until 2014. Since 2017, as the successor to Prof. Dr. hc Herbert Rebscher, he has been responsible for the affairs of DAK-Gesundheit as Chairman of the Board. In his work, he focuses primarily on high, evidence-based quality in medical care and a guarantee of nursing care infrastructure, supplemented by tax-based financing and a base-peak exchange in long-term care. In an interview with "Monitor Versorgungsforschung" (Monitor for Healthcare Research), he says: "As a health insurance company, you can't just demand that the legislature take action; you also have to want to do something yourself."„
04.04.2019
The legislature had commissioned the Joint Federal Budget Committee with the Statutory Health Insurance Supply Strengthening Act to review the applicable ratios and, based on this, to further develop the requirements planning. The aim is to take greater account of the population's actual care needs and to promote needs-based care close to home. On behalf of the G-BA, an interdisciplinary consortium under the consortium leadership of the Department of Health Services Management at the Ludwig Maximilian University (LMU) Munich has presented a report on the further development of requirements planning within the meaning of Sections 99 ff. SGB V to ensure statutory health care. Against this background, a symposium on “Demand planning and supply in the regions” took place at the LMU Munich on May 23, 2019.
04.04.2019
In oncology, the idea is becoming more and more common that cancer is a disease of genes rather than of the organs affected. This finding is changing research and the question of how patients can be treated in the future. Modern cancer therapies therefore pursue a cross-entity treatment approach. They are directed against the individual attack points of the disease that are responsible for the development and growth of the tumor, such as the test substance entrectinib in NTRK fusion-positive tumors. New findings from this field were presented at the annual meeting of the American Society for Clinical Oncology (ASCO). Experts discussed the extent to which cancer therapy is changing as a result of this rethinking and what effects this has on research at a Roche Pharma event.
04.04.2019
Prof. Dr. Jochen Schmitt, congress president of the German Congress for Health Care Research (DKVF), which is taking place for the 18th time this year, and director of the Center for Evidence-Based Health Care (ZEGV) at the University Hospital Dresden, takes a position on the major task of health care research that lies ahead: the support and promotion of transfer effective concepts and interventions from research into routine care, with the help of which a learning health system can be created.
04.04.2019
The aim of the BMC conference “The Future of the Innovation Fund: From Funding to Standard Care” was to reflect on the current status of the Innovation Fund (IF) and discuss proposals for transferring successful care projects funded by the IF into standard care, which took place in the state representation of Saarland took place. A common thread ran through all of the practical and theoretical lectures, which were then discussed in more detail by leading scientists and experts at so-called topic tables and agreed upon in small groups: The path to standard care will be a difficult, long and equally rocky one.
04.04.2019
On behalf of the European Commission, international health experts made a series of recommendations intended to place redistribution in health systems on a real, values-based basis. The Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) from Vienna was on the panel through its director, Priv. Doc. Dr. phil. Claudia Wild, who calls for a retreat from excess and inadequate care in favor of “high value” health care.
04.04.2019
On June 6th of this year, the Bundestag passed the law for more security in the supply of pharmaceuticals (GSAV). The Federal Council approved it with a narrow majority on June 28th. The packages of measures included are so diverse that in this article the regulations on imports, biosimilars and hemophilia are selectively selected and illuminated using data on the pharmaceutical market.
04.04.2019
Systematic reviews show the multitude of medical interventions that are provided worldwide despite having little to no benefit to patients and sometimes doing more harm than good (Morgan et al. 2019, Brownlee et al. 2017). Studies estimate that around a third of all patients receive medical services that are probably unnecessary, ineffective or even harmful (Ellen et al. 2018). A significant proportion of health spending in OECD countries has no benefit, is wasted and can even cause harm (OECD 2017). In its most recent report, the Advisory Council for the Health Care System once again points to over-, under- and incorrect care and corresponding control deficits in the German health care system (SVR, 2018). As part of the analyzes carried out by the Bertelsmann Foundation's Health Fact Check, significant regional differences were repeatedly identified. These differences are often constant over years and indicate regionally different supply structures, care habits and insufficient evidence-based care and possible overprovision (Bertelsmann Stiftung 2015).